The ESH-EBMT-EHA-IPIG 3rd Translational Research Conference on Bone Marrow Failure and Leukaemia Predisposition Syndromes will be held at Paris, France from November 15-17, 2024.

It will offer valuable insights for both clinical and non-clinical scientists, including M.D.s and Ph.D.s of all levels, who are interested in the biology, pathophysiology, diagnosis, and treatment of bone marrow failure syndromes (BMFS) and predisposition syndromes. The conference will address both acquired and inherited BMFS in adults and children, with a particular focus on emerging principles and innovative treatment strategies.

As is customary for ESH, the event will prioritize accessible interactions between young researchers and established experts, as well as between clinicians and basic scientists. Workshops with experts and poster walks will emphasize key topics and provide opportunities for in-depth discussion. The distinguished faculty will ensure a high standard of clinical, translational, and basic research is maintained throughout the conference.

For Registration Visit Here